Navigation Links
When the mountains call . . .
Date:12/22/2011

When the Mountains Call . . .

. . . don't climb too fast! Lack of acclimatization and excessively rapid ascent are the main risk factors for acute mountain sickness, as Kai Schommer and Peter Brtsch explain in this issue of Deutsches rzteblatt International (Dtsch Arztebl Int 2011; 108 [49]: 839-48).

More and more tourists are climbing up mountains that are 5000 to almost 7000 meters high, such as Kilimanjaro, without any prior experience at high altitudes. The low oxygen content in the air can cause altitude sicknesses of various kinds.

For example, sudden vomiting and intractable headache may be the first signs of high-altitude cerebral edema. Persons who spend 48 hours or more above 4000 meters can suffer an impairment of consciousness that may progress to coma within hours. This disease is fatal if untreated. On the other hand, a noticeable loss of physical performance ability during the ascent and a dry cough are early manifestations of high-altitude pulmonary edema. Persons who fail to heed these warning signs and continue to ascend develop high-altitude cerebral edema as well.

No validated tests are available at present for the preventive assessment of a person's susceptibility to altitude sickness. The authors therefore recommend self-assessment of the following type: anyone who can hike for several hours at a normal pace in the Alps at altitudes of 2500 to 3000 meters ought to be able to tolerate similar exercise one altitude level higher while trekking, though perhaps at a somewhat slower pace.

http://www.aerzteblatt.de/v4/archiv/pdf.asp?id=116424


'/>"/>
Contact: Dr. med. Kai Schommer
kai.schommer@med.uni-heidelberg.de
Deutsches Aerzteblatt International
Source:Eurekalert

Page: 1

Related medicine news :

1. The Marilyn B. Gula Mountains of Hope Foundation donates additional research funds to TGen
2. Connecticut Governor Jodi Rell Honors Mountainside Addiction Treatment Center for its Twelve Years of Operating in Connecticut
3. New York and Connecticut Drug Rehab Center Mountainside Weighs In on Latest White House Budget
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... New York, NY (PRWEB) , ... May 26, 2017 , ... ... "Skin Health & Wound Care" campaign in USA Today, which will educate readers on ... Health side of the campaign, a large focus is placed on melanoma. Dancing with ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device Interface (SDI). Somnoware ... for diagnostic device operations. With this platform, initializing devices and importing studies are ...
(Date:5/26/2017)... ... May 26, 2017 , ... After raising nearly $30,000 on Kickstarter ... to be available at a discounted crowdfunding price on Indiegogo . , “Along ... I also wanted to bring a fidget toy to the market that was made ...
(Date:5/26/2017)... ... May 26, 2017 , ... “When the Stars Lead Home”: a poignant ... of published author Laura Weigel Douglas, an avid reader who lives in the Pacific ... sometimes feels like Green Hills Adventure Camp. She couldn’t be more grateful. , Twelve-year ...
(Date:5/26/2017)... , ... May 26, 2017 , ... Water damage to ... New Jersey School District had left education officials with a number of critical issues ... of the flooring had to be accomplished with little or no disruption to class ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
(Date:5/10/2017)... WASHINGTON , May 10, 2017  The ... doctors or employees of sleep therapy clinics to ... a sleep therapy clinic is involved in a ... as interested in hearing from an employee of ... involved in a kickback scheme to provide medical practice ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... that the Canadian Intellectual Property Office has granted ... Oral Administration of Exenatide". The patent covers Oramed,s ... GLP-1 is an incretin hormone that ...
Breaking Medicine Technology: